Abstract:Cardiac disease and clinical intervention may both lead to an increased risk for thrombosis events due to a modified blood flow in the heart, and thereby a change in the mechanical stimuli of blood cells passing through the chambers of the heart. Specifically, the degree of platelet activation is influenced by the level and type of mechanical stresses in the blood flow. In this article we analyze the blood flow in the left ventricle of the heart through a computational model constructed from patient-specific d… Show more
“…Slow blood flow Turbulence Incomplete apposition [80,81], Hypercoagulability [82,83], Turbulence [84,85], and Incomplete apposition [86,87] can be found through the cited sources. See [2] for a more detailed list of factors involved in prosthetic valve thrombosis.…”
Section: Mitral Valvementioning
confidence: 99%
“…Hemostatic and hemodynamic factors involved in the development of prosthetic valve thromboses. Additional information regarding Slow blood flow[80,81], Hypercoagulability[82,83], Turbulence[84,85], and Incomplete apposition[86,87] can be found through the cited sources. See[2] for a more detailed list of factors involved in prosthetic valve thrombosis.…”
The management of an intracranial hemorrhage in patients receiving anticoagulant therapy presents a significant challenge for medical professionals. Anticoagulant treatment is intended to prevent blood clotting, but it can worsen active brain bleeds. Despite this risk, avoiding the prothrombotic state caused by mechanical heart valves remains crucial. Guidelines on managing this issue are currently lacking, prompting a review that delves into embryonic development and anatomical functions of heart valves, valve replacement therapy for diseased valves, and the need for anticoagulants. Ultimately, recent literature and cases inform discussion regarding how best to manage intracranial hemorrhages in patients with mechanical heart valves. The expectation is that this examination will offer valuable perspectives on the handling of intracranial bleeding among individuals with mechanical heart valves and stimulate additional investigations in this intricate domain, particularly through the lens of applied mechanics.
“…Slow blood flow Turbulence Incomplete apposition [80,81], Hypercoagulability [82,83], Turbulence [84,85], and Incomplete apposition [86,87] can be found through the cited sources. See [2] for a more detailed list of factors involved in prosthetic valve thrombosis.…”
Section: Mitral Valvementioning
confidence: 99%
“…Hemostatic and hemodynamic factors involved in the development of prosthetic valve thromboses. Additional information regarding Slow blood flow[80,81], Hypercoagulability[82,83], Turbulence[84,85], and Incomplete apposition[86,87] can be found through the cited sources. See[2] for a more detailed list of factors involved in prosthetic valve thrombosis.…”
The management of an intracranial hemorrhage in patients receiving anticoagulant therapy presents a significant challenge for medical professionals. Anticoagulant treatment is intended to prevent blood clotting, but it can worsen active brain bleeds. Despite this risk, avoiding the prothrombotic state caused by mechanical heart valves remains crucial. Guidelines on managing this issue are currently lacking, prompting a review that delves into embryonic development and anatomical functions of heart valves, valve replacement therapy for diseased valves, and the need for anticoagulants. Ultimately, recent literature and cases inform discussion regarding how best to manage intracranial hemorrhages in patients with mechanical heart valves. The expectation is that this examination will offer valuable perspectives on the handling of intracranial bleeding among individuals with mechanical heart valves and stimulate additional investigations in this intricate domain, particularly through the lens of applied mechanics.
“…Several mathematical and numerical heart models have been proposed in recent years. Most of them focus on some specific feature of the heart function, by surrogating the remaining ones with models of reduced dimensionality: electrophysiology, 13–20 cardiac mechanics and electromechanics 2,21–33 or computational fluid dynamics (CFD) of the blood 4,34–43 . Only few works also consider the interplay between hemodynamics and cardiac mechanics in a fluid–structure interaction (FSI) framework, 44–48 while neglecting or simplifying the electrical processes generating the contraction 49–52 …”
Section: Introductionmentioning
confidence: 99%
“…Most of them focus on some specific feature of the heart function, by surrogating the remaining ones with models of reduced dimensionality: electrophysiology, [13][14][15][16][17][18][19][20] cardiac mechanics and electromechanics 2,[21][22][23][24][25][26][27][28][29][30][31][32][33] or computational fluid dynamics (CFD) of the blood. 4,[34][35][36][37][38][39][40][41][42][43] Only few works also consider the interplay between hemodynamics and cardiac mechanics in a fluid-structure interaction (FSI) framework, [44][45][46][47][48] while neglecting or simplifying the electrical processes generating the contraction. [49][50][51][52] Albeit each of the above-mentioned models can provide meaningful insight into the cardiac function in both healthy and pathological conditions, they often neglect the feedback mechanisms that relate the different components.…”
We propose a mathematical and numerical model for the simulation of the heart function that couples cardiac electrophysiology, active and passive mechanics and hemodynamics, and includes reduced models for cardiac valves and the circulatory system. Our model accounts for the major feedback effects among the different processes that characterize the heart function, including electro‐mechanical and mechano‐electrical feedback as well as force‐strain and force‐velocity relationships. Moreover, it provides a three‐dimensional representation of both the cardiac muscle and the hemodynamics, coupled in a fluid–structure interaction (FSI) model. By leveraging the multiphysics nature of the problem, we discretize it in time with a segregated electrophysiology‐force generation‐FSI approach, allowing for efficiency and flexibility in the numerical solution. We employ a monolithic approach for the numerical discretization of the FSI problem. We use finite elements for the spatial discretization of partial differential equations. We carry out a numerical simulation on a realistic human left heart model, obtaining results that are qualitatively and quantitatively in agreement with physiological ranges and medical images.
The triple decomposition of a velocity gradient tensor provides an analysis tool in fluid mechanics by which the flow can be split into a sum of irrotational straining flow, shear flow, and rigid body rotational flow. In 2007, Kolář formulated an optimization problem to compute the triple decomposition [V. Kolář, “Vortex identification: New requirements and limitations,” Int. J. Heat Fluid Flow 28, 638–652 (2007)], and more recently, the triple decomposition has been connected to the Schur form of the associated matrix. We show that the standardized real Schur form, which can be computed by state of the art linear algebra routines, is a solution to the optimization problem posed by Kolář. We also demonstrate why using the standardized variant of the real Schur form makes computation of the triple decomposition more efficient. Furthermore, we illustrate why different structures of the real Schur form correspond to different alignments of the coordinate system with the fluid flow and may, therefore, lead to differences in the resulting triple decomposition. Based on these results, we propose a new, simplified algorithm for computing the triple decomposition, which guarantees consistent results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.